Findings

What do systematic reviews say?

6 questions · 6 findings · 1 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1 · 16.7%GRADE not reported 0 · 0%Very low 1 · 16.7%Low 3 · 50%Moderate 1 · 16.7%High 0 · 0%

Closest answers

The findings closest to your search, judged one by one by TypeSafe's Jev model.

Direct match · question page
- H2 receptor antagonists vs sucralfate · Clinically important upper GI bleeding
  Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units 2018 · Cochrane Headline outcomes only
  RR 1.1 [0.87, 1.41]
  24 studies · 3316 participants
  Low
Related · question page
- H2 receptor antagonists vs sucralfate · Nosocomial pneumonia
  Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units 2018 · Cochrane Headline outcomes only
  RR 1.22 [1.07, 1.4]
  17 studies · 3041 participants
  Moderate
Related · question page
- H2 receptor antagonists vs sucralfate · Number of participants requiring blood transfusion
  Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units 2018 · Cochrane Headline outcomes only
  RR 1.25 [0.7, 2.23]
  9 studies · 1095 participants
  Low
Related · question page
- H2 receptor antagonists vs sucralfate · Duration of ICU stay
  Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units 2018 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 1791 participants
  Very low
Related · question page
- H2 receptor antagonists vs sucralfate · All‐cause mortality in ICU
  Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units 2018 · Cochrane Headline outcomes only
  RR 1.09 [0.95, 1.24]
  21 studies · 3178 participants
  Low

H2 receptor antagonists vs sucralfate

Clinically important upper GI bleeding · people admitted to intensive care units

H2 receptor antagonists showed no clear difference in clinically important upper GI bleeding compared with sucralfate (low certainty).

1 finding from 1 review

Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units 2018 · Cochrane Headline outcomes only
RR 1.1 [0.87, 1.41]
24 studies · 3316 participants
Low

H2 receptor antagonists vs sucralfate

Nosocomial pneumonia · people admitted to intensive care units

H2 receptor antagonists probably leads to higher nosocomial pneumonia compared with sucralfate (moderate certainty).

1 finding from 1 review

Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units 2018 · Cochrane Headline outcomes only
RR 1.22 [1.07, 1.4]
17 studies · 3041 participants
Moderate

H2 receptor antagonists vs sucralfate

ICU mortality · people admitted to intensive care units

H2 receptor antagonists showed no clear difference in all‐cause mortality in ICU compared with sucralfate (low certainty).

1 finding from 1 review

Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units 2018 · Cochrane Headline outcomes only
RR 1.09 [0.95, 1.24]
21 studies · 3178 participants
Low

H2 receptor antagonists vs sucralfate

Duration of ICU stay · people admitted to intensive care units

1 finding from 1 review

Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units 2018 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 1791 participants
Very low

H2 receptor antagonists vs sucralfate

Blood transfusion · people admitted to intensive care units

H2 receptor antagonists showed no clear difference in number of participants requiring blood transfusion compared with sucralfate (low certainty).

1 finding from 1 review

Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units 2018 · Cochrane Headline outcomes only
RR 1.25 [0.7, 2.23]
9 studies · 1095 participants
Low

H2 receptor antagonists vs sucralfate

Serious adverse events · people admitted to intensive care units

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found